β-blockade and growth hormone after burn

David W. Hart, Steven Wolf, David L. Chinkes, Sofia O. Lal, Peter I. Ramzy, David Herndon, Basil A. Pruitt, William G. Cioffi

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Objective: To determine whether propranolol and growth hormone (GH) have additive effects to combat burn-induced catabolism. Summary Background Data: Both GH and propranolol have been attributed anabolic properties after severe trauma and burn. It is conceivable that the two in combination would have additive effects. Methods: Fifty-six children with more than 40% TBSA burns were randomized to one of four anabolic regimens: untreated control, GH treatment, propranolol treatment, or combination GH plus propranolol therapy. Clinical treatment was identical for all groups. Resting energy expenditure was determined by indirect calorimetry and skeletal muscle protein kinetics were measured using stable amino acid isotope infusions before and after each anabolic regimen. Results: There were no differences in age, sex, or burn size between groups. Tachycardia and energy expenditure were decreased during propranolol treatment (P < .05). The net balance of muscle protein synthesis and breakdown was improved during proprandol and GH plus propranolol treatment (P < .05). There was no significant benefit of GH alone. No additive effect of combination therapy was seen. Conclusions: Propranolol is a strongly anabolic drug during the early, hypercatabolic period after burn. No synergistic effect between propranolol and GH was identified.

Original languageEnglish (US)
Pages (from-to)450-457
Number of pages8
JournalAnnals of Surgery
Volume236
Issue number4
DOIs
StatePublished - Oct 2002

Fingerprint

Propranolol
Growth Hormone
Muscle Proteins
Burns
Energy Metabolism
Therapeutics
Indirect Calorimetry
Tachycardia
Isotopes
Skeletal Muscle
Amino Acids
Wounds and Injuries
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Surgery

Cite this

Hart, D. W., Wolf, S., Chinkes, D. L., Lal, S. O., Ramzy, P. I., Herndon, D., ... Cioffi, W. G. (2002). β-blockade and growth hormone after burn. Annals of Surgery, 236(4), 450-457. https://doi.org/10.1097/00000658-200210000-00007

β-blockade and growth hormone after burn. / Hart, David W.; Wolf, Steven; Chinkes, David L.; Lal, Sofia O.; Ramzy, Peter I.; Herndon, David; Pruitt, Basil A.; Cioffi, William G.

In: Annals of Surgery, Vol. 236, No. 4, 10.2002, p. 450-457.

Research output: Contribution to journalArticle

Hart, DW, Wolf, S, Chinkes, DL, Lal, SO, Ramzy, PI, Herndon, D, Pruitt, BA & Cioffi, WG 2002, 'β-blockade and growth hormone after burn', Annals of Surgery, vol. 236, no. 4, pp. 450-457. https://doi.org/10.1097/00000658-200210000-00007
Hart DW, Wolf S, Chinkes DL, Lal SO, Ramzy PI, Herndon D et al. β-blockade and growth hormone after burn. Annals of Surgery. 2002 Oct;236(4):450-457. https://doi.org/10.1097/00000658-200210000-00007
Hart, David W. ; Wolf, Steven ; Chinkes, David L. ; Lal, Sofia O. ; Ramzy, Peter I. ; Herndon, David ; Pruitt, Basil A. ; Cioffi, William G. / β-blockade and growth hormone after burn. In: Annals of Surgery. 2002 ; Vol. 236, No. 4. pp. 450-457.
@article{46a8d480545b4a249e430272d52767a3,
title = "β-blockade and growth hormone after burn",
abstract = "Objective: To determine whether propranolol and growth hormone (GH) have additive effects to combat burn-induced catabolism. Summary Background Data: Both GH and propranolol have been attributed anabolic properties after severe trauma and burn. It is conceivable that the two in combination would have additive effects. Methods: Fifty-six children with more than 40{\%} TBSA burns were randomized to one of four anabolic regimens: untreated control, GH treatment, propranolol treatment, or combination GH plus propranolol therapy. Clinical treatment was identical for all groups. Resting energy expenditure was determined by indirect calorimetry and skeletal muscle protein kinetics were measured using stable amino acid isotope infusions before and after each anabolic regimen. Results: There were no differences in age, sex, or burn size between groups. Tachycardia and energy expenditure were decreased during propranolol treatment (P < .05). The net balance of muscle protein synthesis and breakdown was improved during proprandol and GH plus propranolol treatment (P < .05). There was no significant benefit of GH alone. No additive effect of combination therapy was seen. Conclusions: Propranolol is a strongly anabolic drug during the early, hypercatabolic period after burn. No synergistic effect between propranolol and GH was identified.",
author = "Hart, {David W.} and Steven Wolf and Chinkes, {David L.} and Lal, {Sofia O.} and Ramzy, {Peter I.} and David Herndon and Pruitt, {Basil A.} and Cioffi, {William G.}",
year = "2002",
month = "10",
doi = "10.1097/00000658-200210000-00007",
language = "English (US)",
volume = "236",
pages = "450--457",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - β-blockade and growth hormone after burn

AU - Hart, David W.

AU - Wolf, Steven

AU - Chinkes, David L.

AU - Lal, Sofia O.

AU - Ramzy, Peter I.

AU - Herndon, David

AU - Pruitt, Basil A.

AU - Cioffi, William G.

PY - 2002/10

Y1 - 2002/10

N2 - Objective: To determine whether propranolol and growth hormone (GH) have additive effects to combat burn-induced catabolism. Summary Background Data: Both GH and propranolol have been attributed anabolic properties after severe trauma and burn. It is conceivable that the two in combination would have additive effects. Methods: Fifty-six children with more than 40% TBSA burns were randomized to one of four anabolic regimens: untreated control, GH treatment, propranolol treatment, or combination GH plus propranolol therapy. Clinical treatment was identical for all groups. Resting energy expenditure was determined by indirect calorimetry and skeletal muscle protein kinetics were measured using stable amino acid isotope infusions before and after each anabolic regimen. Results: There were no differences in age, sex, or burn size between groups. Tachycardia and energy expenditure were decreased during propranolol treatment (P < .05). The net balance of muscle protein synthesis and breakdown was improved during proprandol and GH plus propranolol treatment (P < .05). There was no significant benefit of GH alone. No additive effect of combination therapy was seen. Conclusions: Propranolol is a strongly anabolic drug during the early, hypercatabolic period after burn. No synergistic effect between propranolol and GH was identified.

AB - Objective: To determine whether propranolol and growth hormone (GH) have additive effects to combat burn-induced catabolism. Summary Background Data: Both GH and propranolol have been attributed anabolic properties after severe trauma and burn. It is conceivable that the two in combination would have additive effects. Methods: Fifty-six children with more than 40% TBSA burns were randomized to one of four anabolic regimens: untreated control, GH treatment, propranolol treatment, or combination GH plus propranolol therapy. Clinical treatment was identical for all groups. Resting energy expenditure was determined by indirect calorimetry and skeletal muscle protein kinetics were measured using stable amino acid isotope infusions before and after each anabolic regimen. Results: There were no differences in age, sex, or burn size between groups. Tachycardia and energy expenditure were decreased during propranolol treatment (P < .05). The net balance of muscle protein synthesis and breakdown was improved during proprandol and GH plus propranolol treatment (P < .05). There was no significant benefit of GH alone. No additive effect of combination therapy was seen. Conclusions: Propranolol is a strongly anabolic drug during the early, hypercatabolic period after burn. No synergistic effect between propranolol and GH was identified.

UR - http://www.scopus.com/inward/record.url?scp=0036785986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036785986&partnerID=8YFLogxK

U2 - 10.1097/00000658-200210000-00007

DO - 10.1097/00000658-200210000-00007

M3 - Article

VL - 236

SP - 450

EP - 457

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 4

ER -